Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 268
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2016  |  Volume : 5  |  Issue : 5  |  Page : 424-429

Expression of human epidermal growth factor receptor 2 and p53 in gastric cancer patients: Clinical and prognosis relevance


1 Department of Molecular Biotechnology of Eukaryotes, Biotechnology Center of Sfax, University of Sfax-, Tunisia
2 Department of Pathology, Habib Bourguiba University Hospital of Sfax-, Tunisia
3 Department of Oncology, Habib Bourguiba University Hospital of Sfax-, Tunisia
4 Department of Surgery, Habib Bourguiba University Hospital of Sfax-, Tunisia

Correspondence Address:
Raja Gargouri
Department of Molecular Biotechnology of Eukaryotes, Biotechnology Center of Sfax, University of Sfax-Tunisia BPK 1177, 3018 Sfax
Tunisia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2278-0513.197866

Rights and Permissions

Background: Increased evidence showed that human epidermal growth factor receptor 2 (HER2) and p53 play an important role in gastric cancer development and could have a prognostic relevance. We aimed to study the expression of HER2 and p53 in gastric adenocarcinomas and to investigate the correlation with clinicopathological parameters as well as the overall survival in Tunisian patients. Patients and sMethods: A total of 95 patients who had undergone gastrectomy for gastric adenocarcinoma at Sfax University Hospital of Tunisia were included in this study. The expression of HER2 and p53 in tumor tissues was performed by immunohistochemistry. Results: Positive expression of HER2 was observed in 17.89% of cases while p53 nuclear expression was negative in 40%, moderate in 38.94%, and intense in 21.05% of tumor tissues. The expression of HER2 correlated significantly with patient's age (P = 0.011), histological type (P = 0.005), tumor differentiation (P = 0.009), and tumor node metastasis (TNM) stage (P = 0.048). On the other hand, the expression of p53 correlated with patient's age (P = 0.028), gender (P = 0.022), and TNM stage (P = 0.029). With regard to the prognostic value, negative nuclear expression of p53 alone or associated with loss of HER2 expression correlated significantly with prolonged overall survival (P log rank = 0.019 and 0.002, respectively). Conclusion: Our findings highlight the importance of HER2 and p53 proteins as predictive markers for prognosis allowing a better management of patients with gastric adenocarcinoma.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed929    
    Printed23    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal